Self-Expanding Polymeric Stent Segmentation for Radial Strength

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional medical implants, particularly those made of metallic stents and biodegradable polymers, face limitations such as thrombosis, restenosis, poor expandability, and uncontrolled degradation, as well as challenges in drug elution and mechanical strength, which hinder their effectiveness in treating medical conditions.

Innovation Solution

Development of self-expanding tubular medical devices made from polymeric or metallic strands with a support coating, featuring a therapeutic agent like paclitaxel, designed to expand and maintain strength while delivering a low dose of drug effectively, with improved radial strength and controlled drug release properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If biodegradable and biostable polymeric materials are used for stents, then long-term effects of permanent implants are eliminated, but expandability and mechanical properties deteriorate

Engineering Contradiction:
Improveelimination of long-term effectsVSAvoidexpandability and mechanical properties
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The stent is segmented into multiple struts and cells, allowing the polymeric structure to achieve sufficient mechanical strength through geometric configuration rather than material properties alone. The segmented design enables the stent to expand and provide radial support while using biodegradable materials.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses composite polymeric materials that combine biodegradable components with enhanced mechanical properties. The composite structure allows the stent to maintain strength and expandability during the critical period before degradation completes, while ultimately being absorbed by the body.

Inventive Principle:
Principle #40Composite materials

2Volume of moving object

If low-profile design with small diameter fibers is used, then device profile is reduced, but expansion characteristics and radial strength deteriorate

Engineering Contradiction:
Improvedevice profileVSAvoidexpansion characteristics and radial strength
Core Design Contradiction:
Volume of moving objectVSStrength

Solution Approach 1:

The stent is divided into multiple thin struts arranged in a lattice pattern. This segmentation allows each individual strut to remain thin and flexible for low-profile delivery, while the collective arrangement of numerous struts provides sufficient radial strength and expansion characteristics when deployed.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The stent design transitions from a solid thick-walled structure to a three-dimensional lattice framework. This dimensional change allows the device to maintain a low profile during delivery while achieving adequate radial strength through the spatial arrangement and interconnection of multiple thin struts in three dimensions.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Reliability

If drug-eluting polymer coatings are added to metallic stents, then restenosis risk is decreased, but device complexity and manufacturing difficulty increase

Engineering Contradiction:
Improverestenosis preventionVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention merges the structural function of the stent with the drug delivery function into a single integrated polymeric component. Rather than adding a separate coating layer to a metallic stent, the drug-eluting functionality is incorporated directly into the biodegradable polymeric stent material itself, simplifying the overall device structure and manufacturing process.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS20200230300A1Drug-eluting medical implants
Publication Date: 2020.07.23 LYRA THERAPEUTICS INC
  • US20200230300A1 patent drawing
  • US20200230300A1 patent drawing
  • US20200230300A1 patent drawing

AI summary

Disclosed are self-expanding medical implants for placement within a lumen of a patient. The implants comprise a woven or non-woven structure having a substantially tubular configuration, and are designed to be low-profile such that they are deliverable with a small diameter catheter. The implants have a high recoverability and desired mechanical properties.